Pfizer on June 1 said it has completed its application for emergency use authorization from the FDA for its three-dose COVID-19 vaccine in children under 5, The Wall Street Journal reports.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,